XML 31 R20.htm IDEA: XBRL DOCUMENT v3.21.2
Loss Per Share
6 Months Ended
Jun. 30, 2021
Loss Per Share [Abstract]  
Loss Per Share

Note 13 – Loss Per Share

 

The weighted-average common shares outstanding are as follows:

 

 

 

Three Months Ended
June 30,

 

 

Six Months Ended
June 30,

 

 

 

2021

 

 

2020

 

 

2021

 

 

2020

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding

 

 

14,863,069

 

 

 

12,405,011

 

 

 

14,783,459

 

 

 

12,385,946

 

Issuance of warrants

 

 

5,297,341

 

 

 

-

 

 

 

5,300,740

 

 

 

 

Weighted average common shares outstanding - basic

 

 

20,160,410

 

 

 

12,405,011

 

 

 

20,084,199

 

 

 

12,385,946

 

Dilutive effect of employee stock options and nonvested share awards

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Weighted average common shares outstanding - diluted

 

 

20,160,410

 

 

 

12,405,011

 

 

 

20,084,199

 

 

 

12,385,946

 

 

 

The Company computes earnings per share using the two-class method, which is an earnings allocation formula that determines earnings per share for common stock and participating securities. The Company’s participating securities are its grants of restricted stock which contain non-forfeitable rights to dividends. The Company allocates earnings between both classes; however, in periods of undistributed losses, they are only allocated to common shares as the unvested restricted stockholders do not contractually participate in losses of the Company. The Company computes basic earnings per share by dividing net income allocated to common shareholders by the weighted average number of shares outstanding during the period. Warrants issued in connection with the Company's long-term debt were issued at a nominal exercise price and are considered outstanding at the date of issuance. Diluted earnings per share is calculated to give effect to all potentially dilutive common shares that were outstanding during the period. Weighted average diluted common shares outstanding include the incremental shares that would be issued upon the assumed exercise of stock options and the assumed vesting of nonvested share awards. For the three months ended June 30, 2021 and 2020, 1,329,429 and 1,107,304 shares, respectively, were not included in the weighted average common shares outstanding calculation as they were anti-dilutive. For the six months ended June 30, 2021and 2020, 1,531,864 and 1,076,577 shares, respectively, were not included in the weighted average common shares outstanding calculation as they were anti-dilutive.